|
11/03/2021 |
CIGB2020- ARI elderly contacts |
CIGB |
Registered outdated |
|
2010-12-20 |
CIGB500 in healthy volunteers |
CIGB |
Registered |
|
05/09/2017 |
CIMAbior® in CD20-positive B-cell Non-Hodgkin Lymphoma |
CIM |
Registered |
|
05/08/2014 |
CIMAVax EGF in Lung Cancer in PHC. Phase IV |
CIM |
Registered |
|
11/08/2020 |
CIMAvax-EGF in Bladder cancer |
CIM |
Registered outdated |
|
12/05/2021 |
CIMAvax-EGF in different maintenance schemes |
CIM |
Registered outdated |
|
22/10/2020 |
CIMAvax-EGF in patients at high risk of lung cancer |
CIM |
Registered outdated |
|
14/12/2015 |
CIMAvax-EGF vaccine Predictor Phase IV |
CIM |
Registered outdated |
|
03/08/2018 |
CIMAvax-EGF-Platelets-Adults- Lung Cancer |
CIM |
Registered |
|
20/10/2021 |
CIMAvax-EGF/Lung cancer/Biomarkers/Prospective CT |
CIM |
Registered |
|
17/10/2018 |
CIMAvax-EGF® in metastatic asymptomatic or mildly symptomatic Castration Resistant Prostate Cancer patients. Phase II-III Clinical Trial |
CIM |
Registered |
|
18/06/2021 |
CIMAvax-EGF®-post-COVID19 convalescent with respiratory disorders-adults-Phase II (CORVAXCIM) |
CIM |
Registered outdated |
|
2009-02-26 |
CITOPROT-III |
CIGB |
Registered |
|
2009-03-13 |
Clinical evaluation of the effect anti-inflammatory of the extract of Mangifera indica L. (Vimang®) in patients with diagnosis of Bronchial Asthma |
CQF |
Registered |
|
2011-05-16 |
Clinical Trial Heberbiovac HB vaccine Material Reference Batch |
CIGB |
Registered |
|
2008-07-29 |
Clinical trial to evaluate the safety, reactogenicity and immunogenicity of the vax-TyVi vaccine in volunteers between 18 and 20 years of age. |
FINLAY |
Registered |
|
2013-06-19 |
Clinical Trial with the Outer Membrane Vesicles (OMV) Bivalent AW135 Anti meningocóccal Vacccine Candidate |
FINLAY |
Registered |
|
2010-12-24 |
Clinical trial, phase II, to evaluate rhEGF efficacy and safety at a dose of 25 or 75 micrograms intralesionally in patients with diabetic foot ulcer (Wagner grade 1 or 2). |
CIGB |
Registered |
|
2010-12-27 |
Clinical trial, phase II: Evaluation of TheraCIM hR3 MaB combined with chemo- and radio-therapy to treat patients with epithelial tumors in neck of the uterus, stage III. |
CIM |
Registered |
|
31/08/2021 |
Cocoa catabolites |
kmunoz |
Registered |
